Article
Exosome based multivalent vaccine: achieving potent immunization, broadened reactivity…
medRxiv · 2023 · Cacciottolo, M.; Nice, J. B.; Li, Y.; LeClaire, M. J.; Twaddle, R.; Mora, C. L.; Adachi, S. Y.; Chin, E. R.; Young, M.; Angeles, J.; Elliott, K.; Sun, M.
Key facts
| Title | Exosome based multivalent vaccine: achieving potent immunization, broadened reactivity, and strong T cell responses with nanograms of proteins |
|---|---|
| First author | Cacciottolo, M.; Nice, J. B.; Li, Y.; LeClaire, M. J.; Twaddle, R.; Mora, C. L.; Adachi, S. Y.; Chin, E. R.; Young, M.; Angeles, J.; Elliott, K.; Sun, M. |
| Journal | medRxiv |
| Published | Jan 19, 2023 |
| DOI | 10.1101/2023.01.10.523356 |
| Devices mentioned | K073490, K964870 |
| Product codes mentioned | CEK, CFN, MVU, GQG |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1